The following is a summary of “Diagnostic-avoiding Chlamydia trachomatis variants detected in cervical and endometrial ...
Background: In adolescents and young females, abnormal vaginal discharge (AVD) is of prevalent concern. The syndromic therapy ...
“Some STIs can make you more susceptible to other STIs,” Ross said. Untreated gonorrhea and chlamydia, for example, can increase the risk of contracting HIV if you have sex with someone who is ...
Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States ...
Credit: DC Studio/Shutterstock. Aptima has completed its Small Business Innovation Research (SBIR) Phase I contract with the US Air Force Research Laboratory, marking a key milestone in the ...
The researchers recruited 193 women, ages 25 to 65, and instructed them to use vaginal swabs, which were then sent to the laboratory. The volunteers also underwent speculum exams. Testing of all ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Hologic's Aptima SARS-CoV-2 assay ... RNA from nasopharyngeal (NP) or nasal swab samples collected from individuals ...
The Aptima SARS-CoV-2 Assay is an in vitro diagnostic test that detects SARS-CoV-2 RNA from nasopharyngeal (NP) or nasal swab samples obtained from people exhibiting signs and symptoms of a ...
The assay identifies SARS-CoV-2 RNA from NP or nasal swab samples collected from individuals showing ... The US Food and Drug Administration (FDA) has granted 510(k) clearance to Hologic’s Aptima SARS ...
The Aptima SARS-CoV-2 Assay is an in vitro diagnostic test that detects SARS-CoV-2 RNA from nasopharyngeal (NP) or nasal swab samples obtained from people exhibiting signs and symptoms of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback